U.S. Capital Wealth Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$324K	Buy	+3,126	New	+$330K	0.01%	799
2022 Q2	–	Sell	-23,147	Closed	-$1.84M	–	722
2022 Q1	$1.84M	Sell	23,147 -111	-0.5%	-$8.61K	0.07%	272
2021 Q4	$1.89M	Buy	23,258 +447	+2%	+$35.3K	0.07%	270
2021 Q3	$1.76M	Buy	+22,811	New	+$1.84M	0.08%	271

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

U.S. Capital Wealth Advisors's PJP Position: Q1 2026 in Review

U.S. Capital Wealth Advisors opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 3,126 shares worth $324K. The stake represents 0.01% of the portfolio and ranks #799 among its holdings. This is a return to the name: U.S. Capital Wealth Advisors previously reported a position in PJP as recently as Q1 2022.

U.S. Capital Wealth Advisors first reported a position in PJP in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.89M in Q4 2021. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

U.S. Capital Wealth Advisors held 3,126 shares of Invesco Pharmaceuticals ETF worth $324K as of Q1 2026.
Invesco Pharmaceuticals ETF was a new U.S. Capital Wealth Advisors position in Q1 2026.
Invesco Pharmaceuticals ETF made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #799 holding.
U.S. Capital Wealth Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2021 and has held it in 4 quarters since.
U.S. Capital Wealth Advisors's Invesco Pharmaceuticals ETF position peaked at $1.89M in Q4 2021.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.